TickerFactsScreenerDevelopers

Xenon Pharmaceuticals Inc. (XENE) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$3.15M2013: $9.71M2014: $11.11M2015: -$9.36M2016: -$24.82M2017: -$32.58M2018: -$38.04M2019: -$42.82M2020: -$31.30M2021: -$78.99M2022: -$129.14M2023: -$214.05M2024: -$279.30M2025: -$373.07M-$373.07M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$373.07M-33.6%
2024-$279.30M-30.5%
2023-$214.05M-65.7%
2022-$129.14M-63.5%
2021-$78.99M-152.4%
2020-$31.30M+26.9%
2019-$42.82M-12.6%
2018-$38.04M-16.8%
2017-$32.58M-31.3%
2016-$24.82M-165.1%
2015-$9.36M-184.3%
2014$11.11M+14.4%
2013$9.71M+408.0%
2012-$3.15M—